GoKawiilBiotech firms expand pet longevity drugs and $50,000 cloning services
Companies including Loyal are testing longevity drugs for dogs, with one trial involving roughly 1,300 pet dogs in the US targeting metabolic health, alongside other firms developing treatments for age-related conditions like obesity and osteoarthritis, and even cat longevity medicines. Separately, Viagen Pets offers pet cloning for $50,000, producing a genetic twin rather than an exact replica by implanting a pet's DNA into a donor egg and growing it in a surrogate.
GoKawiil's interpretation of the reporting above, not reported fact.
The rise of pet longevity drugs and cloning services suggests a growing commercial market built around grief and the desire to extend or replicate companionship with animals. Researcher Lori Kogan's comments imply that the lack of established mourning rituals for pets may be driving demand for such extreme interventions, though whether these technologies genuinely ease loss remains an open question.
- Loyal is trialing a metabolic health drug in about 1,300 dogs as part of broader pet longevity research.
- Viagen Pets charges $50,000 to clone cats and dogs, producing genetic twins, not exact replicas.
- Experts suggest the absence of formal mourning rituals for pets may fuel interest in cloning and longevity treatments.
PetSafe Smart Feed Automatic Feeder — As longevity science increasingly focuses on metabolic health in pets, a smart feeder helps you manage portion control and feeding schedules precisely, supporting healthy weight management. It's a practical, available-today way to care for your pet's wellbeing while the more futuristic biotech options develop.
See PetSafe Smart Feed Automatic Feeder on Amazon → Affiliate link — we may earn a commission on purchases, at no extra cost to you. Product picked by AI based on this article; it is not a tested recommendation.Source: technologyreview.com — Jessica Hamzelou, 2026-10-16
Published there as: “Can’t bear to say goodbye to your pet? Biotech’s got you covered.”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.